Induction of HIV-1-specific immunity after vaccination with apoptotic HIV-1/murine leukemia virus-infected cells

Journal of Immunology

Volumn 169, Issue 10, 2002, Pages 5771-5779

  Spetz, Anna Lena ^a   Sörensen, Anna Smed ^a   Walther Jallow, Lilian ^a   Wahren, Britta ^a   Andersson, Jan ^a   Holmgren, Lars ^a   Hinkula, Jorma ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; VIRUS ANTIGEN; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; DOSE RESPONSE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNITY; IMMUNIZATION; MOUSE; MUCOSAL IMMUNITY; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; SPLEEN CELL; T LYMPHOCYTE; VACCINATION; VIRUS INDUCTION; VIRUS INFECTION;

EID: 0037111306     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.10.5771     Document Type: Article

References (53)

1. Henson, P. M., D. L. Bratton, and V. A. Fadok. 2001. The phosphatidylserine receptor: A crucial molecular switch? Nat. Rev. Mol. Cell Biol. 2:627.
2. Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991.
3. Matzinger, P. 1998. An innate sense of danger. Semin. Immunol. 10:399.
4. Gallucci, S., M. Lolkema, and P. Matzinger. 1999. Natural adjuvants: Endogenous activators of dendritic cells. Nat. Med. 5:1249.
5. Sauter, B., M. L. Albert, L. Francisco, M. Larsson, S. Somersan, and N. Bhardwaj. 2000. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191:423.
6. Krieg, A. M. 1996. Lymphocyte activation by CpG dinucleotide motifs in prokaryotic DNA. Trends Microbiol. 4:73.
7. Ying, H., T. Z. Zaks, R. F. Wang, K. R. Irvine, U. S. Kammula, F. M. Marincola, W. W. Leitner, and N. P. Restifo. 1999. Cancer therapy using a self-replicating RNA vaccine. Nat. Med. 5:823.
8. Restifo, N. P. 2000. Building better vaccines: How apoptotic cell death can induce inflammation and activate innate and adaptive immunity. Curr. Opin. Immunol. 12:597.
9. Medzhitov, R., and C. Janeway, Jr. 2000. Innate immune recognition: Mechanisms and pathways. Immunol. Rev. 173:89.
10. Rovere, P., C. Vallinoto, A. Bondanza, M. C. Crosti, M. Rescigno, P. Ricciardi-Castagnoli, C. Rugarli, and A. A. Manfredi. 1998. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J. Immunol. 161:4467.
11. Albert, M. L., B. Sauter, and N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86.
12. + killer T cells. J. Exp. Med. 193:405.
13. + T cells by dendritic cells. J. Virol. 74:10018.
14. + T cells: Cross-priming in infectious diseases. Curr. Opin. Immunol. 13:437.
15. Holmgren, L., A. Szeles, E. Rajnavolgyi, J. Folkman, G. Klein, I. Ernberg, and K. I. Falk. 1999. Horizontal transfer of DNA by the uptake of apoptotic bodies. Blood 93:3956.
16. Spetz, A. L., B. K. Patterson, K. Lore, J. Andersson, and L. Holmgren. 1999. Functional gene transfer of HIV DNA by an HIV receptor-independent mechanism. J. Immunol. 163:736.
17. Bergsmedh, A., A. Szeles, M. Henriksson, A. Bratt, M. J. Folkman, A. L. Spetz, and L. Holmgren. 2001. Horizontal transfer of oncogenes by uptake of apoptotic bodies. Proc. Natl. Acad. Sci. USA 98:6407.
18. Brander, C., and B. D. Walker. 1999. T lymphocyte responses in HIV-1 infection: Implications for vaccine development. Curr. Opin. Immunol. 11:451.
19. Kalams, S. A., P. J. Goulder, A. K. Shea, N. G. Jones, A. K. Trocha, G. S. Ogg, and B. D. Walker. 1999. Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy. J. Virol. 73:6721.
20. Ogg, G. S., X. Jin, S. Bonhoeffer, P. Moss, M. A. Nowak, S. Monard, J. P. Segal, Y. Cao, S. L. Rowland-Jones, A. Hurley, et al. 1999. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J. Virol. 73:797.
21. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat. Med. 5:518.
22. Calarota, S., G. Bratt, S. Nordlund, J. Hinkula, A. C. Leandersson, E. Sandstrom, and B. Wahren. 1998. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancet 351:1320.
23. Hel, Z., D. Venzon, M. Poudyal, W. P. Tsai, L. Giuliani, R. Woodward, C. Chougnet, G. Shearer, J. D. Altman, D. Watkins, et al. 2000. Viremia control following antiretroviral treatment and therapeutic immunization during primary S1V251 infection of macaques. Nat. Med. 6:1140.
24. Cohen, J. 2001. Building a small-animal model for AIDS, block by block. Science 293:1034.
25. Spector, D. H., E. Wade, D. A. Wright, V. Koval, C. Clark, D. Jaquish, and S. A. Spector. 1990. Human immunodeficiency virus pseudotypes with expanded cellular and species tropism. J. Virol. 64:2298.
26. Andang, M., J. Hinkula, G. Hotchkiss, S. Larsson, S. Britton, F. Wong-Staal, B. Wahren, and L. Ahrlund-Richter. 1999. Dose-response resistance to HIV-1/ MuLV pseudotype virus ex vivo in a hairpin ribozyme transgenic mouse model. Proc. Natl. Acad. Sci. USA 96:12749.
27. Isaguliants, M. G., N. N. Petrakova, B. Zuber, K. Pokrovskaya, R. Gizatullin, D. A. Kostyuk, A. Kjerrstrom, G. Winberg, S. N. Kochetkov, J. Hinkula, and B. Wahren. 2000. DNA-encoding enzymatically active HIV-1 reverse transcriptase, but not the inactive mutant, confers resistance to experimental HIV-1 challenge. Intervirology 43:288.
28. Spetz, A. L., J. Strominger, and V. Groh-Spies. 1996. T cell subsets in normal human epidermis. Am. J. Pathol. 149:665.
29. Lyamuya, E., U. Bredberg-Raden, J. Albert, O. Grankvist, V. Msangi, C. Kagoma, F. Mhalu, and G. Biberfeld. 1997. Comparison of in-house and commercial sample preparation and PCR amplification systems for detection of human immunodeficiency virus type 1 DNA in blood samples from Tanzanian adults. J. Clin. Microbiol. 35:278.
30. Lowell, G. H., R. W. Kaminski, T. C. VanCott, B. Slike, K. Kersey, E. Zawoznik, L. Loomis-Price, G. Smith, R. R. Redfield, S. Amselem, and D. L. Birx. 1997. Proteosomes, emulsomes, and cholera toxin B improve nasal immunogenicity of human immunodeficiency virus gp160 in mice: Induction of serum, intestinal, vaginal, and lung IgA and IgG. J. Infect. Dis. 175:292.
31. Asakura, Y., P. Lundholm, A. Kjerrstrom, R. Benthin, E. Lucht, J. Fukushima, S. Schwartz, K. Okuda, B. Wahren, and J. Hinkula. 1999. DNA-plasmids of HIV-1 induce systemic and mucosal immune responses. Biol. Chem. 380:375.
32. Lundholm, P., Y. Asakura, J. Hinkula, E. Lucht, and B. Wahren. 1999. Induction of mucosal IgA by a novel jet delivery technique for HIV-1 DNA. Vaccine 17:2036.
33. Rich, T., R. L. Allen, and A. H. Wyllie. 2000. Defying death after DNA damage. Nature 407:777.
34. Broliden, P. A., A. von Gegerfelt, P. Clapham, J. Rosen, E. M. Fenyo, B. Wahren, and K. Broliden. 1992. Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins. Proc. Natl. Acad. Sci. USA 89:461.
35. Muster, T., F. Steindl, M. Purtscher, A. Trkola, A. Klima, G. Himmler, F. Ruker, and H. Katinger. 1993. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J. Virol. 67:6642.
36. Sigal, L. J., S. Crotty, R. Andino, and K. L. Rock. 1999. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 398:77.
37. + T-cell responses from chronically infected individuals. J. Virol. 75:2142.
38. Larsson, M., J. F. Fonteneau, M. Lirvall, P. Haslett, J. D. Lifson, and N. Bhardwaj. 2002. Activation of HIV-1 specific CD4 and CD8 T cells by human dendritic cells: Roles for cross-presentation and non-infectious HIV-1 virus. AIDS 16:1319.
39. + T-cell reactivity by dendritic cells loaded with HIV-1 X4-infected apoptotic cells. J. Virol. 76:3007.
40. Servet-Delprat, C., P. O. Vidalain, O. Azocar, F. Le Deist, A. Fischer, and C. Rabourdin-Combe. 2000. Consequences of Fas-mediated human dendritic cell apoptosis induced by measles virus. J. Virol. 74:4387.
41. Ignatius, R., M. Marovich, E. Mehlhop, L. Villamide, K. Mahnke, W. I. Cox, F. Isdell, S. S. Frankel, J. R. Mascola, R. M. Steinman, and M. Pope. 2000. Canarypox virus-induced maturation of dendritic cells is mediated by apoptotic cell death and tumor necrosis factor-α secretion. J. Virol. 74:11329.
42. Sasaki, S., R. R. Amara, A. E. Oran, J. M. Smith, and H. L. Robinson. 2001. Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases. Nat. Biotechnol. 19:543.
43. Mantis, N. J., P. A. Kozlowski, D. W. Mielcarz, W. Weissenhorn, and M. R. Neutra. 2001. Immunization of mice with recombinant gp41 in a systemic prime/mucosal boost protocol induces HIV-1-specific serum IgG and secretory IgA antibodies. Vaccine 19:3990.
44. Wu, H. Y., and M. W. Russell. 1994. Comparison of systemic and mucosal priming for mucosal immune responses to a bacterial protein antigen given with or coupled to cholera toxin (CT) B subunit, and effects of pre-existing anti-CT immunity. Vaccine 12:215.
45. Lanzavecchia, A., and F. Sallusto. 2001. Regulation of T cell immunity by dendritic cells. Cell 106:263.
46. Shi, Y., W. Zheng, and K. L. Rock. 2000. Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses. Proc. Natl. Acad. Sci. USA 97:14590.
47. Zocchi, M. R., A. Poggi, and A. Rubartelli. 1997. The RGD-containing domain of exogenous HIV-1 Tat inhibits the engulfment of apoptotic bodies by dendritic cells. AIDS 11:1227.
48. Xu, X. N., G. R. Screaton, F. M. Gotch, T. Dong, R. Tan, N. Almond, B. Walker, R. Stebbings, K. Kent, S. Nagata, et al. 1997. Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells. J. Exp. Med. 186:7.
49. Piguet, V., O. Schwartz, S. Le Gall, and D. Trono. 1999. The downregulation of CD4 and MHC-I by primate lentiviruses: A paradigm for the modulation of cell surface receptors. Immunol. Rev. 168:51.
50. Geleziunas, R., W. Xu, K. Takeda, H. Ichijo, and W. C. Greene. 2001. HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell. Nature 410:834.
51. Wolf, D., V. Witte, B. Laffert, K. Blume, E. Stromer, S. Trapp, P. d'Aloja, A. Schurmann, and A. S. Baur. 2001. HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals. Nat. Med. 7:1217.
52. + T lymphocytes in HIV-infected individuals following antiretroviral therapy. Curr. Opin. Immunol. 13:483.
53. Malim, M. H., and M. Emerman. 2001. HIV-1 sequence variation: Drift, shift, and attenuation. Cell 104:469.